Show simple item record

dc.contributor.authorHaapala, Eero, A.
dc.date.accessioned2025-02-04T12:06:38Z
dc.date.available2025-02-04T12:06:38Z
dc.date.issued2025
dc.identifier.citationHaapala, E. (2025). Identifying adolescents with increased cardiometabolic risk : Simple, but challenging. <i>Jornal de Pediatria</i>, <i>101</i>(1), 1-3. <a href="https://doi.org/10.1016/j.jped.2024.10.001" target="_blank">https://doi.org/10.1016/j.jped.2024.10.001</a>
dc.identifier.otherCONVID_243642206
dc.identifier.urihttps://jyx.jyu.fi/handle/123456789/99954
dc.description.abstractThe prevalence of increased cardiometabolic risk, such as insulin resistance and type 2 diabetes, has increased worldwide in adolescents.1 Insulin resistance and type 2 diabetes in childhood and adolescence predict insulin resistance, type 2 diabetes, and preclinical atherosclerosis23 as well as retinal and kidney disease4 in adulthood. In addition to the individual-level burden of these diseases, the economic costs of type 2 diabetes are measured in billions of US dollars.56 Therefore, to counteract these adverse effects and increased economic burden, the early identification of children and adolescents with increased risk of insulin resistance and type 2 diabetes is essential. However, objective methods, such as fasting blood samples or glucose tolerance tests, may not be commonly available or feasible at, for example, school healthcare centers due to the costs and the lack of appropriately trained laboratory staff. Therefore, indirect, affordable, and feasible indicators helping to identify youth with increased risk of cardiometabolic diseases are warranted.en
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofseriesJornal de Pediatria
dc.rightsCC BY 4.0
dc.titleIdentifying adolescents with increased cardiometabolic risk : Simple, but challenging
dc.typejournal article
dc.identifier.urnURN:NBN:fi:jyu-202502041734
dc.contributor.laitosLiikuntatieteellinen tiedekuntafi
dc.contributor.laitosFaculty of Sport and Health Sciencesen
dc.type.urihttp://purl.org/eprint/type/JournalItem
dc.type.coarhttp://purl.org/coar/resource_type/c_6501
dc.description.reviewstatusnonPeerReviewed
dc.format.pagerange1-3
dc.relation.issn0021-7557
dc.relation.numberinseries1
dc.relation.volume101
dc.type.versionpublishedVersion
dc.rights.copyright© 2024 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda
dc.rights.accesslevelopenAccessfi
dc.type.publicationarticle
dc.subject.ysoinsuliiniresistenssi
dc.subject.ysoaikuistyypin diabetes
dc.subject.ysoennustettavuus
dc.subject.ysonuoret
dc.subject.ysoindikaattorit
dc.subject.ysokehonkoostumus
dc.subject.ysosydän- ja verisuonitaudit
dc.format.contentfulltext
jyx.subject.urihttp://www.yso.fi/onto/yso/p22290
jyx.subject.urihttp://www.yso.fi/onto/yso/p8303
jyx.subject.urihttp://www.yso.fi/onto/yso/p9701
jyx.subject.urihttp://www.yso.fi/onto/yso/p11617
jyx.subject.urihttp://www.yso.fi/onto/yso/p8365
jyx.subject.urihttp://www.yso.fi/onto/yso/p26989
jyx.subject.urihttp://www.yso.fi/onto/yso/p9886
dc.rights.urlhttps://creativecommons.org/licenses/by/4.0/
dc.relation.doi10.1016/j.jped.2024.10.001
dc.type.okmB1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

CC BY 4.0
Except where otherwise noted, this item's license is described as CC BY 4.0